Increase of Parkinson disability after fluoxetine medication.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 8423889.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Depression is a major clinical feature of Parkinson's disease. We report the increased amount of motor disability in four patients with idiopathic Parkinson's disease after exposure to the antidepressant fluoxetine. The possibility of a clinically relevant dopamine-antagonistic capacity of fluoxetine in Parkinson's disease patients must be considered.
Medical subject headings
- Fluoxetine
- Parkinson Disease, Secondary